135 completed, 30 unknown, 27 terminated, 12 recruiting. 143 Phase 2, 54 Phase 1, 38 Phase 3, 9 Not applicable, 1 Phase 4.
Follow Carmustine: new trials by email Literature Review of Carmustine trials Research Report on Carmustine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tebentafusp-tebn With LDT in Metastatic UM Tebentafusp-Tebn, GM-CSF (Sargramostim), BCNU - Metastatic Uveal Melanoma | Phase 1 / Phase 2 | Recruiting | Thomas Jefferson University | 109 | 2025-10-15 | 2026-07-21 |
| Orelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL Treatment Orelabrutinib, Rituximab (R), BEAM (carmustine (BCNU), etoposide, cytarabine, melphalan) - Mantle Cell Lymphoma (MCL) | Phase 2 | Recruiting | Ruijin Hospital | 45 | 2025-07-01 | 2025-09-30 |
| A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma VI-0609, BiCNU - Lymphoma, Non-Hodgkin Lymphoma | Phase 2 | Recruiting | VIVUS LLC | 49 | 2025-03-12 | 2026-03-27 |
| CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant Thiotepa, Carmustine, Autologous Stem Cell Transplant - Diffuse Large B Cell Lymphoma | Phase 2 | Recruiting | Washington University School of Medicine | 36 | 2025-01-16 | 2026-08-28 |
| Tazemetostat Plus CHOP in 1L T-cell Lymphoma Tazemetostat, Doxorubicin, Vincristine - Lymphoma, Peripheral T Cell Lymphoma | Phase 2 | Withdrawn | Eric Jacobsen, MD | 2024-12-24 | 2026-04-01 | |
| MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma Pembrolizumab, Autologous stem cell transplant, Carmustine - Autologous Stem Cell Transplant, Classic Hodgkin Lymphoma | Phase 2 | Recruiting | Masonic Cancer Center, University of Minnesota | 28 | 2024-12-04 | 2026-09-29 |
| Efficacy and Safety of Venetoclax Combined With BEAM Pretreatment in Autologous Transplantation for DLBCL Venetoclax, Carmustine, Cytarabine - Diffuse Large B Cell Lymphoma | Not applicable | Unknown | Ruijin Hospital | 52 | 2023-06-01 | 2023-05-18 |
| Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT modified BEAM, BEAM - Autologous Stem Cell Transplantation, Conditioning | Not applicable | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 122 | 2023-04-15 | 2023-04-18 |
| Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) Dapagliflozin, Carmustine, Topotecan - Pediatric Brain Tumor, Pediatric Solid Tumor | Phase 1 | Recruiting | Washington University School of Medicine | 20 | 2023-04-03 | 2026-06-10 |
| Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma Autologous Hematopoietic Stem Cell Transplantation, Carmustine, Cytarabine - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Phase 1 | Withdrawn | Fred Hutchinson Cancer Center | 2023-04-01 | 2023-01-13 | |
| hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) P140K-MGMT, O6-benzylguanine, Photon Based Radiotherapy - Glioblastoma Multiforme, Glioblastoma Multiforme, Adult | Phase 2 | Recruiting | Leland Metheny | 16 | 2023-01-20 | 2026-09-10 |
| ChiCGB vs BEAM in High-risk or R/R Lymphomas Chidamide, Cladribine, Gemcitabine - Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell | Phase 3 | Unknown | Sichuan University | 306 | 2022-07-01 | 2022-07-25 |
| B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021 Cyclophosphamide, Cytarabine, Dexamethasone, Etoposide, Ifosfamide, Methotrexate, Cyclophosphamide, Cytarabine, Dexamethasone, Etoposide, Ifosfamide, Methotrexate, Vincristine, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin hydrochloride, Etoposide, Ifosfamide, Methotrexate, vincristine - Non-hodgkin Lymphoma,B Cell, Burkitt Lymphoma | Phase 4 | Recruiting | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 300 | 2022-05-25 | 2022-08-26 |
| Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma Basiliximab, Carmustine, Cytarabine - Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma | Phase 2 | Recruiting | City of Hope Medical Center | 33 | 2021-11-02 | 2025-12-04 |
| Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases Carmustine, Ethiodized Oil, Transarterial Chemoembolization - Metastatic Malignant Neoplasm in the Liver, Metastatic Uveal Melanoma | Phase 2 | Active not recruiting | Thomas Jefferson University | 28 | 2021-09-27 | 2026-05-06 |
| RL-MPV Followed by BBC HCT Using Autologous Stem Cells and Maintenance Therapy With Nivolumab for Newly Diagnosed PCNSL Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide - Primary CNS Lymphoma | Phase 2 | Unknown | National Research Center for Hematology, Russia | 30 | 2021-05-17 | 2022-06-21 |
| SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells Melphalan, BCNU, Vitamin B12B - Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation | Phase 1 | Recruiting | General Oncology, Inc. | 24 | 2021-01-13 | 2026-01-29 |
| A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease Carmustine 7.7Mg Wafer - Brain Tumor - Metastatic | Phase 2 | Recruiting | University of Nebraska | 100 | 2020-11-06 | 2026-04-28 |
| Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma Yttrium Y 90 Basiliximab, Carmustine, Etoposide - Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma | Phase 1 | Completed | City of Hope Medical Center | 20 | 2020-06-08 | 2025-03-20 |
| A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma Selinexor, Temozolomide (TMZ), Lomustine (CCNU) - Glioblastoma Multiforme | Phase 1 / Phase 2 | Terminated | Karyopharm Therapeutics Inc | 74 | 2020-06-08 | 2024-12-16 |
Showing 20 of 222. Sign in to see all of them.
Lymphoma (74) · Lymphoma, Large B-Cell, Diffuse (55) · Lymphoma, Non-Hodgkin (54) · Glioblastoma (41) · Lymphoma, Mantle-Cell (40) · Lymphoma, Follicular (37) · Hodgkin Disease (36) · Central Nervous System Neoplasms (32) · Gliosarcoma (29) · Astrocytoma (28) · Brain Neoplasms (28) · Lymphoma, Large-Cell, Immunoblastic (26) · Burkitt Lymphoma (25) · Leukemia, Lymphocytic, Chronic, B-Cell (22) · Multiple Myeloma (22)
Memorial Sloan Kettering Cancer Center (13) · M.D. Anderson Cancer Center (11) · Fred Hutchinson Cancer Center (10) · City of Hope Medical Center (9) · Duke University (9) · National Cancer Institute (NCI) (8) · University of Maryland, Baltimore (8) · University of Nebraska (8) · Alliance for Clinical Trials in Oncology (7) · SWOG Cancer Research Network (7) · Masonic Cancer Center, University of Minnesota (6) · Stanford University (6) · Washington University School of Medicine (6) · Case Comprehensive Cancer Center (5) · Radiation Therapy Oncology Group (5)
United States (171) · Germany (16) · United Kingdom (15) · Canada (13) · Italy (11) · France (10) · Belgium (8) · Netherlands (8) · Switzerland (7) · Australia (6) · Austria (6) · China (6) · Czechia (6) · Poland (5) · Denmark (4)
Henry S. Friedman, MD (7) · Aaron P. Rapoport, MD (3) · Amrita Y. Krishnan, MD (3) · Barry R. Meisenberg, MD (3) · Daniel J. Weisdorf, MD (3) · Issa F. Khouri, MD (3) · Julie M Vose, MD (3) · Ajay Gopal (2) · Alessandro Olivi, MD (2) · Andrew Cluster, M.D. (2) · Craig Moskowitz, MD (2) · David C. Linch (2) · Eileen P. Smith, MD (2) · Gene David Resnick, MD (2)
PMID 22689675, PMID 34515338, PMID 12721262, PMID 1403051, PMID 14769138, PMID 15073861, PMID 15234047, PMID 15465203, PMID 15667956, PMID 15761020, PMID 15890570, PMID 16033132, PMID 16432076, PMID 16525139, PMID 16750317, PMID 16932345, PMID 17264335, PMID 17339189, PMID 17404368, PMID 17941066, PMID 17971487, PMID 18077791, PMID 18248979, PMID 18723297, PMID 19021050, PMID 19188181, PMID 19204207, PMID 19533025, PMID 19917845, PMID 20032498, PMID 20063115, PMID 20383558, PMID 20637881, PMID 20660832, PMID 20800387, PMID 21073974, PMID 21552302, PMID 21602899, PMID 22102709, PMID 22250189, PMID 22490331, PMID 23091101, PMID 23242601, PMID 23547078, PMID 23834234, PMID 24171516, PMID 24531550, PMID 24625415, PMID 24687837, PMID 25072780
P30CA015704 (7), U10CA032102 (7), P30CA033572 (5), P30CA043703 (5), P30CA016672 (4), P30CA022453 (4), U01CA062502 (4), P01CA030206 (3), P01CA044991 (2), P30CA008748 (2), P30CA036727 (2), P30CA093373 (2), U01CA121947 (2), U01HL069294 (2), U10CA031946 (2)